Unknown

Dataset Information

0

Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury.


ABSTRACT: Acetaminophen (APAP) is a widely used over-the-counter antipyretic and analgesic drug. Overdose of APAP is the leading cause of hospital admission for acute liver failure. Montelukast is an antagonist of cysteinyl leukotriene receptor 1 (Cysltr1), which protects from inflammation and oxidative stress. However, the function of montelukast in APAP-induced hepatotoxicity remains unknown. In this study, we examined whether pharmacological inhibition of Cystlr1 could protect mice against APAP-induced hepatic damage. We found that APAP treatment upregulated messenger RNA and protein levels of Cysltr1 both in vitro and in vivo. Pharmacological inhibition of Cysltr1 by montelukast ameliorated APAP-induced acute liver failure. The hepatoprotective effect of montelukast was associated with upregulation of hepatic glutathione/glutathione disulfide level, reduction in c-Jun-NH2-terminal kinase activation and oxidative stress. In mouse primary hepatocytes, inhibition of Cysltr1 by montelukast ameliorated the expression of inflammatory-related genes and APAP-induced cytotoxicity. We conclude that montelukast may be used to treat APAP-induced acute hepatic injury.

SUBMITTER: Pu S 

PROVIDER: S-EPMC6759817 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury.

Pu Shiyun S   Liu Qinhui Q   Li Yanping Y   Li Rui R   Wu Tong T   Zhang Zijing Z   Huang Cuiyuan C   Yang Xuping X   He Jinhan J  

Frontiers in pharmacology 20190918


Acetaminophen (APAP) is a widely used over-the-counter antipyretic and analgesic drug. Overdose of APAP is the leading cause of hospital admission for acute liver failure. Montelukast is an antagonist of cysteinyl leukotriene receptor 1 (Cysltr1), which protects from inflammation and oxidative stress. However, the function of montelukast in APAP-induced hepatotoxicity remains unknown. In this study, we examined whether pharmacological inhibition of Cystlr1 could protect mice against APAP-induced  ...[more]

Similar Datasets

| S-EPMC5758662 | biostudies-literature
| S-EPMC2908515 | biostudies-literature
| S-EPMC10136285 | biostudies-literature
| S-EPMC4955750 | biostudies-literature
| S-EPMC7058798 | biostudies-literature
| S-EPMC9739375 | biostudies-literature
| S-EPMC7212374 | biostudies-literature
| S-EPMC7827407 | biostudies-literature
| S-EPMC3534780 | biostudies-literature
| S-EPMC9137993 | biostudies-literature